Indivior Pharmaceuticals Inc
← Back to INDV Overview

Indivior Pharmaceuticals Inc (INDV)

Revenue & Top-Line Growth

Latest Revenue

$317M

Financial Fundamentals

INDVQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.32B-11.5%+19.2%1.29B+10.2%
2025-12-310.36B+14.0%+19.7%1.24B+4.3%
2025-09-300.31B+4.0%+2.3%1.18B-0.2%
2025-06-300.30B+13.5%+1.0%1.17B+2.4%
2025-03-310.27B-11.0%-6.3%1.17B+4.2%
2024-12-310.30B-2.6%+2.0%1.19B+8.8%
2024-09-300.31B+2.7%+13.3%1.18B+13.5%
2024-06-300.30B+5.3%+8.3%1.15B+14.4%
2024-03-310.28B-3.1%+12.3%1.12B+18.6%
2023-12-310.29B+8.1%+21.1%1.09B+21.2%
2023-09-300.27B-1.8%+16.8%1.04B+18.0%
2023-06-300.28B+9.1%+24.9%1.00B
2023-03-310.25B+4.5%+22.2%0.95B
2022-12-310.24B+4.3%+8.5%0.90B
2022-09-300.23B+5.0%0.88B
2022-06-300.22B+6.8%0.00B
2022-03-310.21B-7.2%0.00B
2021-12-310.22B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20251.24B+4.3%
20241.19B+8.7%
20231.09B+21.3%
20220.90B+13.9%
20210.79B+22.3%
20200.65B-17.6%
20190.79B-18.2%
20180.96B-16.4%
20171.15B+18.5%
20160.97B